{
    "organizations": [],
    "uuid": "45cb079fe7b3ee65301a30fed80c7fded91fba8b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-keryx-biopharmaceuticals-q4-loss-p/brief-keryx-biopharmaceuticals-q4-loss-per-share-0-26-idUSASB0C4FM",
    "ord_in_thread": 0,
    "title": "BRIEF-Keryx Biopharmaceuticals Q4 Loss Per Share $0.26",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 7, 2018 / 12:09 PM / in 9 minutes BRIEF-Keryx Biopharmaceuticals Q4 Loss Per Share $0.26 Reuters Staff \nFeb 7 (Reuters) - Keryx Biopharmaceuticals Inc: \n* KERYX BIOPHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS * Q4 LOSS PER SHARE $0.26 * Q4 REVENUE $18.7 MILLION VERSUS $9.5 MILLION \n* CASH AND CASH EQUIVALENTS AS OF DEC 31, 2017 TOTALED ABOUT $93.5 MILLION Source text for Eikon: Further company coverage:",
    "published": "2018-02-07T14:09:00.000+02:00",
    "crawled": "2018-02-07T14:21:09.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "biopharmaceuticals",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "keryx",
        "biopharmaceuticals",
        "inc",
        "keryx",
        "biopharmaceuticals",
        "announces",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "revenue",
        "million",
        "versus",
        "million",
        "cash",
        "cash",
        "equivalent",
        "dec",
        "totaled",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}